These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2197312)

  • 1. Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results.
    Feinstein SB; Cheirif J; Ten Cate FJ; Silverman PR; Heidenreich PA; Dick C; Desir RM; Armstrong WF; Quinones MA; Shah PM
    J Am Coll Cardiol; 1990 Aug; 16(2):316-24. PubMed ID: 2197312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients.
    Geny B; Mettauer B; Muan B; Bischoff P; Epailly E; Piquard F; Eisenmann B; Haberey P
    J Am Coll Cardiol; 1993 Oct; 22(4):1193-8. PubMed ID: 8409060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the Phase III Albunex Multicenter Trial.
    Crouse LJ; Cheirif J; Hanly DE; Kisslo JA; Labovitz AJ; Raichlen JS; Schutz RW; Shah PM; Smith MD
    J Am Coll Cardiol; 1993 Nov; 22(5):1494-500. PubMed ID: 8227810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast opacification of left ventricular myocardium following intravenous administration of sonicated albumin microspheres.
    Sanders WE; Cheirif J; Desir R; Zoghbi WA; Hoyt BD; Schulz PE; Quiñones MA
    Am Heart J; 1991 Dec; 122(6):1660-5. PubMed ID: 1957761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of intravenous Albunex injections on pulmonary arterial pressure, gas exchange, and left ventricular peak intensity.
    Walker R; Wiencek JG; Aronson S; Zaroff J; Glock D; Thisted R; Feinstein SB
    J Am Soc Echocardiogr; 1992; 5(5):463-70. PubMed ID: 1389214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing myocardial perfusion with Albunex during coronary artery bypass surgery: technical considerations and safety of aortic root injections.
    Aronson S; Savage R; Fernandez A; Klein A; Young C; Toledano A; Lee BK; Karp RB; Lytle B; Loop F
    J Cardiothorac Vasc Anesth; 1996 Oct; 10(6):713-8. PubMed ID: 8910149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a new intravenous echo contrast agent (BY 963) with Albunex for opacification of left ventricular cavity.
    Leischik R; Beller KD; Erbel R
    Basic Res Cardiol; 1996; 91(1):101-9. PubMed ID: 8660247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial.
    Cohen JL; Cheirif J; Segar DS; Gillam LD; Gottdiener JS; Hausnerova E; Bruns DE
    J Am Coll Cardiol; 1998 Sep; 32(3):746-52. PubMed ID: 9741522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intrapulmonary arterial injection of Albunex for left heart contrast echocardiography].
    Fukui O; Lim YJ; Nakatani D; Kawano S; Kodama K; Masuyama T; Asanuma H; Hori M; Mishima M
    J Cardiol; 1998 Feb; 31(2):99-107. PubMed ID: 9513037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opacification and border delineation improvement in patients with suboptimal endocardial border definition on routine echocardiography: results of a phase III trial of sonicated albumin microspheres.
    Crouse LJ; Kramer PH
    Clin Cardiol; 1991 Nov; 14(11 Suppl 5):V19-22. PubMed ID: 1764836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial contrast enhancement after intravenous injection of sonicated albumin microbubbles: a transesophageal echocardiography dipyridamole study.
    Voci P; Bilotta F; Merialdo P; Agati L
    J Am Soc Echocardiogr; 1994; 7(4):337-46. PubMed ID: 7917341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular opacification by intravenous contrast echocardiography.
    Castini D; Gentile F; Ornaghi M; Mangiarotti E; Garbin M; Ravaglia R; Gioventù M; Mantero A; Corno R; Limido A; Morandi F; Fiorentini C; Pezzano A; Repetto S; Haider T; Morris H; Marelli C
    G Ital Cardiol; 1999 Jun; 29(6):620-9. PubMed ID: 10396665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracoronary and aortic root myocardial contrast echocardiography: the effect of route, dose, and pharmacologic coronary vasodilation.
    Bach DS; Armstrong WF; Collins T; Muller DW; Ramee SR; Bruns DE; Cheirif J
    J Am Soc Echocardiogr; 1995; 8(5 Pt 1):719-27. PubMed ID: 9417216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digital radiofrequency echocardiography in the detection of myocardial contrast following intravenous administration of Albunex.
    Monaghan MJ; Metcalfe JM; Odunlami S; Waaler A; Jewitt DE
    Eur Heart J; 1993 Sep; 14(9):1200-9. PubMed ID: 8223734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albunex: a safe and effective commercially produced agent for myocardial contrast echocardiography.
    Keller MW; Glasheen W; Kaul S
    J Am Soc Echocardiogr; 1989; 2(1):48-52. PubMed ID: 2627424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast echocardiography in coronary artery diseased patients: effect of systemic and pulmonary artery pressures on left heart opacification after intravenous injection of Albunex.
    Geny B; Piquard F; Muan B; Epailly E; Lambrechs M; Thiranos JC; Petit H; Eisenmann B; Haberey P
    Coron Artery Dis; 1997 Feb; 8(2):77-81. PubMed ID: 9211046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sonicated albumin in exercise echocardiography: technique and feasibility to enhance endocardial visualization.
    Yvorchuk KJ; Sochowski RA; Chan KL
    J Am Soc Echocardiogr; 1996; 9(4):462-9. PubMed ID: 8827629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability of echocardiographic measurements of myocardial perfusion using commercially produced sonicated serum albumin (Albunex).
    Klein AL; Bailey AS; Moura A; Murray RD; Morehead AJ; Brum J; Pearce G; Stewart WJ; Thomas JD
    J Am Coll Cardiol; 1993 Dec; 22(7):1983-93. PubMed ID: 8245358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection.
    Skyba DM; Camarano G; Goodman NC; Price RJ; Skalak TC; Kaul S
    J Am Coll Cardiol; 1996 Nov; 28(5):1292-300. PubMed ID: 8890829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing albunex in the left ventricle: an analysis of the technical parameters of four ultrasound systems in canines and humans.
    Block RJ; Brodsky L; Ostoic T; Fernandez A; Hickle P; Devries S; Bieniarz T; In M; Feinstein SB
    J Am Soc Echocardiogr; 1996; 9(6):787-94. PubMed ID: 8943438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.